Sign in

NCT06166758Completed

Feasibility Study: Educational Genetic Test Video

Pilot Feasibility Study: Educational Genetic Test Video

Source: ClinicalTrials.gov · Last updated 29 May 2024

Brief summary (registry, in English)

Assess whether introducing an educational video regarding the benefits, risks, and limitations of genetic testing affects prostate cancer patients' decisional conflict regarding receiving germline genetic testing.

Status (registry)
Completed
Study type
Interventional
Enrollment
14 (actual)
First submitted
1 Dec 2023
Start date
14 Dec 2023
Primary completion date
15 Mar 2024
Lead sponsor
Virginia Commonwealth University
NCT number
NCT06166758

What you commit to

  • Study type: Interventional
  • Participants enrolled: 14
  • From 14 Dec 2023 to the primary completion date, 15 Mar 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Adults unable to consent
  • Individuals who are not yet adults (infants, children, teenagers)
  • Pregnant individuals
  • Prisoners

Who the study is looking for

  • Prostate cancer patients who have been prescribed germline genetic testing by their provider
  • Understand written and spoken English
  • Have not received germline genetic testing for hereditary cancer risk in the past

Age in the registry: 18 years to - · Sex: Male · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Virginia Commonwealth University
Coordinator of this site? Confirm its status
RichmondUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.